Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation.

Saved in:

Bibliographic Details
Title:	Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation.
Authors:	Lien WC; Department of Physical Medicine and Rehabilitation National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan, Republic of China.; Department of Physical Medicine and Rehabilitation, College of Medicine National Cheng Kung University Tainan Taiwan, Republic of China.; Ph.D. Program in Tissue Engineering and Regenerative Medicine National Chung Hsing University Taichung City Taiwan, Republic of China., Zhou XR; Institute of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan, Republic of China., Liang YJ; Institute of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan, Republic of China., Ching CT; Ph.D. Program in Tissue Engineering and Regenerative Medicine National Chung Hsing University Taichung City Taiwan, Republic of China.; Graduate Institute of Biomedical Engineering National Chung Hsing University Taichung City Taiwan, Republic of China., Wang CY; Department of Cell Biology and Anatomy, College of Medicine National Cheng Kung University Tainan Taiwan, Republic of China.; Institute of Basic Medical Sciences, College of Medicine National Cheng Kung University Tainan Taiwan, Republic of China., Lu FI; Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology National Cheng Kung University Tainan Taiwan, Republic of China.; The iEGG and Animal Biotechnology Center National Chung Hsing University Taichung City Taiwan, Republic of China., Chang HC; Department of Physical Medicine and Rehabilitation, College of Medicine National Cheng Kung University Tainan Taiwan, Republic of China., Lin FH; Ph.D. Program in Tissue Engineering and Regenerative Medicine National Chung Hsing University Taichung City Taiwan, Republic of China.; Institute of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan, Republic of China.; Institute of Biomedical Engineering and Nanomedicine National Health Research Institutes Zhunan, Miaoli Taiwan, Republic of China., Wang HD; Ph.D. Program in Tissue Engineering and Regenerative Medicine National Chung Hsing University Taichung City Taiwan, Republic of China.; Graduate Institute of Biomedical Engineering National Chung Hsing University Taichung City Taiwan, Republic of China.; Graduate Institute of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan, Republic of China.; Department of Medical Laboratory Science and Biotechnology China Medical University Taichung City Taiwan, Republic of China.
Source:	Bioengineering & translational medicine [Bioeng Transl Med] 2022 Jun 13; Vol. 8 (1), pp. e10346. Date of Electronic Publication: 2022 Jun 13 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101689146 Publication Model: eCollection Cited Medium: Print ISSN: 2380-6761 (Print) Linking ISSN: 23806761 NLM ISO Abbreviation: Bioeng Transl Med Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2380-6761
DOI:	10.1002/btm2.10346